MARKETS

BSE Prices delayed by 5 minutes... Prices as on Feb 23, 2018   ABB India 1521.95 [ 0.73% ]ACC 1646.8 [ 0.94% ]Ambuja Cements Ltd. 259.7 [ 1.11% ]Asian Paints Ltd. 1101.9 [ -1.29% ]Axis Bank Ltd. 536.55 [ 1.24% ]Bajaj Auto Ltd. 2988 [ 0.57% ]Bank of Baroda 145.6 [ 1.68% ]Bharti Airtel 425.45 [ 2.26% ]Bharat Heavy Ele 92.9 [ 1.81% ]Bharat Petroleum 430.1 [ 0.62% ]Britannia Ind. 4963.7 [ 2.12% ]Cairn India Ltd. 285.4 [ 0.90% ]Cipla 595.15 [ 0.90% ]Coal India Ltd. 310.55 [ -0.48% ]Colgate Palm. 1049.9 [ 0.46% ]Dabur India 329.05 [ 0.63% ]DLF Ltd. 225 [ 2.13% ]Dr. Reddy's Labs 2169.25 [ 2.26% ]GAIL (India) Ltd. 458.35 [ -1.63% ]Grasim Inds. 1133.75 [ 2.11% ]HCL Technologies 956.1 [ 1.60% ]HDFC 1824.05 [ 0.35% ]HDFC Bank 1879.8 [ 1.34% ]Hero MotoCorp 3498.65 [ 0.47% ]Hindustan Unilever L 1323 [ -0.16% ]Hindalco Indus. 246.55 [ 2.71% ]ICICI Bank 321.3 [ 1.04% ]IDFC L 52.95 [ 2.42% ]Indian Hotels Co 131.8 [ -0.53% ]IndusInd Bank 1642.9 [ 1.14% ]Infosys 1155.65 [ -0.42% ]ITC Ltd. 269.05 [ 0.71% ]Jindal St & Pwr 264.7 [ 5.37% ]Kotak Mahindra Bank 1079.85 [ 0.67% ]L&T 1302.35 [ 0.86% ]Lupin Ltd. 807.15 [ 0.73% ]Mahi. & Mahi 719.3 [ -0.22% ]Maruti Suzuki India 8705.3 [ 0.63% ]MTNL 23.65 [ -2.47% ]Nestle India 7582.5 [ 0.56% ]NIIT Ltd. 94.55 [ -0.89% ]NMDC Ltd. 130.5 [ 2.84% ]NTPC 162.8 [ 1.43% ]ONGC 190 [ 2.04% ]Punj. NationlBak 113.4 [ -1.09% ]Power Grid Corpo 193.25 [ 1.20% ]Reliance Inds. 934 [ 1.09% ]SBI 276.1 [ 1.28% ]Vedanta 337.5 [ 2.82% ]Shipping Corpn. 73.05 [ 0.14% ]Sun Pharma. 570.2 [ 5.17% ]Tata Chemicals 706.5 [ 1.28% ]Tata Global Beverage 270.8 [ 3.22% ]Tata Motors Ltd. 360.45 [ 0.53% ]Tata Steel 677.8 [ 6.26% ]Tata Power Co. 85.65 [ 0.71% ]Tata Consultancy 3076.9 [ 1.20% ]Tech Mahindra Ltd. 620.4 [ 3.03% ]UltraTech Cement 4115.75 [ 0.29% ]United Spirits 3237.5 [ 2.48% ]Wipro Ltd 294.15 [ 0.60% ]Zee Entertainment En 570.2 [ 0.65% ]

News Details

You can view in detail.
Lupin's US arm recalls 12,888 bottles of ulcer drug in US 13/09/2017 14:42

Drug firm Lupin's US arm, Lupin Pharmaceuticals Inc, is recalling 12,888 bottles of Famotidine for oral suspension used in treatment of ulcers from the American market.

The reason for the recall is current Good Manufacturing Practise (CGMP) deviations, United States Food and Drug Administration (USFDA) said in its latest Enforcement Report.

Lupin Pharmaceuticals Inc is recalling 12,888 bottles of Famotidine for oral suspension USP, 40 mg/5 ml, 50 ml bottle, manufactured by Lupin Ltd at its Goa facility, it added.

The ongoing nation wide voluntary recall is a class III recall, the report said.

Famotidine for oral suspension is indicated in short-term treatment of active duodenal ulcer, active benign gastric ulcer and gastroesophageal reflux disease.

As per the USFDA, a class III recall is initiated in "a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences".

Meanwhile, shares of Lupin were trading at Rs 988.90 apiece, up 0.77 per cent from the previous close at 14:45 hours on BSE.

LOAD MORE